Natera, Inc.
NASDAQ:NTRAMedical - Diagnostics & Research
+$2.23 today
- Market cap
- $41.98B
- Beta
- 1.54
- P/E (TTM)
- -143.0
- EPS (TTM)
- -$1.60
Volume 1.96M
Average 1.41M
NTRA Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Natera, Inc.NASDAQ: NTRA
Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026
Other non-cash items dips below year-ago levels
Q2 FY2026 other non-cash items of $1.34M fell 70.2% year over year, behind the +48.5% change in trailing-twelve-month other non-cash items. Sequentially, it fell 89.5% from the prior quarter. Over 3 fiscal years it compounded at -20.0% a year.
Context
- Other non-cash items amounted to 0.7% of revenue in FY2025, down 0.4 pp from a year earlier.
- Other non-cash items increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -70.2% toward the trailing-twelve-month pace of +48.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 15.53M USD
- Year-over-year change
- -16.3%
- 4-year CAGR
- -27.3%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.53M | -16.3% |
| FY2024 | 2024-12-31 | 18.55M | -6.7% |
| FY2023 | 2023-12-31 | 19.89M | -34.5% |
| FY2022 | 2022-12-31 | 30.36M | -45.4% |
| FY2021 | 2021-12-31 | 55.61M | — |
Other Non-Cash Items vs competitors
How NTRA compares with its peers on the latest reported figures
- NTRA's LTM Jun 2026 other non-cash items of $24.21M is the 4th largest of the 8 companies compared; the peer median is $14.63M.
- Its year-over-year change of +48.5% is the 5th highest of 7, against a peer median of +272.9%.
- Other non-cash items amounts to 0.9% of revenue for NTRA, versus a peer median of 7.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $333.2M | +401.1% | -11.4% | 40.2% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $43.3M | +1288.4% | -55.5% | 9.5% |
| LTM Mar 2026 | $24.63M | +144.7% | -29.6% | 7.7% | |
| LTM Jun 2026 | $24.21M | +48.5% | -20.0% | 0.9% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $14.63M | — | — | 3.7% |
| LTM Jun 2026 | $7.63M | -134.0% | +0.6% | 1.4% | |
| LTM Mar 2026 | $2.84M | -113.5% | — | 4.4% | |
| LTM Mar 2026 | $699K | +677.7% | +55.5% | 1226.3% | |
| Peer median (excluding NTRA) | $14.63M | +272.9% | -11.4% | 7.7% | |
Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (471.72M) | (547.8M) | (434.8M) | (190.43M) | (208.16M) |
| Depreciation & Amortization | 11.25M | 16.7M | 24.1M | 30.97M | 43.48M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 115.22M | 152.38M | 191.81M | 274.43M | 354.4M |
| Change in Working Capital | (45.6M) | (83.15M) | (47.95M) | 2.14M | 10.05M |
| Accounts Receivables | (43.51M) | (122.31M) | (33.9M) | (35.88M) | 20.75M |
| Inventory | (6.88M) | (8.5M) | (5.35M) | (3.99M) | (20.87M) |
| Accounts Payables | 19.22M | 5.46M | (15.46M) | 13.21M | 753K |
| Other Working Capital | (14.44M) | 42.2M | 6.76M | 28.79M | 9.41M |
| Other Non-Cash Items | 55.61M | 30.36M | 19.89M | 18.55M | 15.53M |
| Operating Cash Flow | (335.24M) | (431.5M) | (246.96M) | 135.66M | 215.3M |
| Capital Expenditures | (41.03M) | (47.7M) | (39.2M) | (66.42M) | (106.19M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (16.02M) |
| Purchases of Investments | (876.1M) | (86.95M) | (98.3M) | (124.68M) | 0 |
| Sales of Investments | 720.49M | 464.98M | 306M | 339.22M | 23M |
| Other Investing Activities | (8.56M) | 0 | 0 | (10.5M) | 0 |
| Investing Cash Flow | (205.19M) | 330.34M | 168.5M | 137.62M | (132.21M) |
| Debt Repayment | 0 | 30M | 0 | (82K) | 0 |
| Common Stock Issued | 576.19M | 452.64M | 254.46M | 30.29M | 47.46M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 576.19M | 482.64M | 254.46M | 30.2M | 47.46M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.76M | 381.48M | 176M | 303.49M | 130.55M |
| Free Cash Flow | (376.27M) | (479.2M) | (286.15M) | 69.24M | 109.11M |
Natera, Inc.
NASDAQ:NTRA
Intrinsic Alpha fair value
Locked
Current Price
$289.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.